(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
1.89% $ 10.80
@ $10.28
Wydano: 14 vas. 2024 @ 16:30
Zwrot: 5.06%
Poprzedni sygnał: vas. 12 - 22:25
Poprzedni sygnał:
Zwrot: -3.95 %
Live Chart Being Loaded With Signals
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients...
Stats | |
---|---|
Dzisiejszy wolumen | 135 657 |
Średni wolumen | 277 176 |
Kapitalizacja rynkowa | 387.11M |
EPS | $0 ( 2024-03-20 ) |
Następna data zysków | ( $-1.020 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.43 |
ATR14 | $0.0140 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-07 | Gall Matthew | Buy | 163 200 | Stock Option (Right to Buy) |
2024-03-07 | Call Matthew | Buy | 225 000 | Stock Option (Right to Buy) |
2024-03-07 | Mcgrath Yvonne | Buy | 153 600 | Stock Option (Right to Buy) |
2024-03-07 | Detheux Michel | Buy | 590 400 | Stock Option (Right to Buy) |
2024-03-07 | Desimone Jill | Buy | 44 766 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
64.32 |
Last 98 transactions |
Buy: 4 056 310 | Sell: 3 240 538 |
Wolumen Korelacja
iTeos Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
VERU | 0.964 |
AADI | 0.945 |
MDRX | 0.944 |
TWST | 0.941 |
SGMO | 0.941 |
LSBK | 0.939 |
BLNK | 0.936 |
ACRS | 0.936 |
AKTX | 0.936 |
ALHC | 0.936 |
10 Najbardziej negatywne korelacje | |
---|---|
CPTA | -0.934 |
RAM | -0.928 |
SGEN | -0.924 |
TYHT | -0.916 |
GPACU | -0.906 |
DRNA | -0.902 |
PESI | -0.897 |
XPON | -0.891 |
AMPH | -0.886 |
MLAI | -0.886 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
iTeos Therapeutics, Inc. Korelacja - Waluta/Towar
iTeos Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $12.60M |
Zysk brutto: | $11.70M (92.87 %) |
EPS: | $-3.15 |
FY | 2023 |
Przychody: | $12.60M |
Zysk brutto: | $11.70M (92.87 %) |
EPS: | $-3.15 |
FY | 2022 |
Przychody: | $267.63M |
Zysk brutto: | $266.82M (99.70 %) |
EPS: | $2.72 |
FY | 2021 |
Przychody: | $344 775 |
Zysk brutto: | $344 775 (100.00 %) |
EPS: | $0.00881 |
Financial Reports:
No articles found.
iTeos Therapeutics, Inc.
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej